{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T19:33:02Z","timestamp":1747164782477,"version":"3.40.5"},"reference-count":5,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jhep.2024.05.019","type":"journal-article","created":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T16:06:13Z","timestamp":1716221173000},"page":"e133-e134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Correspondence on \u201cIncidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis\u201d"],"prefix":"10.1016","volume":"81","author":[{"given":"Francesca","family":"Colapietro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0561-7902","authenticated-orcid":false,"given":"Ana","family":"Lleo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2024.05.019_bib1","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1016\/j.jhep.2024.03.025","article-title":"Hepatocellular carcinoma in patients with autoimmune hepatitis","volume":"81","author":"Pasta","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2024.05.019_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2024.03.009","article-title":"Expanding the dialogue: a closer look at AIH management and HCC risk","author":"Shan","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2024.05.019_bib3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.14309\/ajg.0000000000001525","article-title":"Increased cancer risk in autoimmune hepatitis: a Danish nationwide cohort study","volume":"117","author":"Jensen","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2024.05.019_bib4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejim.2018.03.006","article-title":"Synergistic effect of oral corticosteroids use on risk of hepatocellular carcinoma in high risk populations","volume":"52","author":"Lai","year":"2018","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jhep.2024.05.019_bib5","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/HEP.0000000000000589","article-title":"Lack of complete biochemical\u00a0response in autoimmune hepatitis leads to adverse outcome: first\u00a0report of the IAIHG retrospective registry","volume":"79","author":"Slooter","year":"2024","journal-title":"Hepatology"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827824003544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827824003544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T04:25:40Z","timestamp":1724387140000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827824003544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":5,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0168827824003544"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2024.05.019","relation":{},"ISSN":["0168-8278"],"issn-type":[{"type":"print","value":"0168-8278"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correspondence on \u201cIncidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis\u201d","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2024.05.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2023.09.010","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2024.03.025","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2024.03.009","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Association for the Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}